This week: Consider how your DNA could make you less secure, learn about how a controversial doctor from Massachusetts General Hospital is helping to improve diabetes treatment, and get all the details of the next big Hacakthon in San Francisco!
A survey of people who have taken part in clinical trials indicates that participants care more about the benefits to science than the risk of sharing their personal data.
A mechanism enabling cells to bind and isolate toxic substances could have significant implications for how tumours develop resistance to certain types of chemotherapy.
Researchers have developed a new method for correcting the errors that creep into DNA barcodes, yielding far more accurate results and paving the way for more ambitious medical research in the future.
Scientists have produced pigs that can resist one of the world’s most costly animal diseases, by changing their genetic code. And the animals show no signs that the change in their DNA has had any other impact on their health or wellbeing — yet.
To understand the biology of diseased organs, researchers can use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types.
We’d all dearly like to see a cure for the common cold, but it never quite seems to arrive. So what’s the hold-up — and will it be over soon? Getting rid of this scourge is nothing to be sneezed at.
The U.S. Patent and Trademark Office has decided to grant not just one, but two new CRISPR patents to UC Berkeley, home of pioneer Jennifer Doudna, who many consider the creator of the technology.
Computational researchers have developed a computer program which has revealed a previously unknown combination of drugs that may be the answer to triple-negative breast cancer.
Researchers from the Mayo Clinic recommends genetic testing for all pancreatic cancer patients as the new standard of care, after finding six genetic mutations in patients with no family history of the disease.
When it comes to understanding what makes people tick—and get sick—medical science has long assumed that the bigger the sample of human subjects, the better. New research suggests this big data approach may be wildly off the mark.
The Wellcome Sanger Institute has provided evidence and made recommendations for an inquiry by the UK Parliament Science and Technology Committee into an immigration system that works for science and innovation, following Brexit.